Literature DB >> 17211989

Further description of early clinically silent lupus nephritis.

M E Zabaleta-Lanz1, L E Muñoz, F J Tapanes, R E Vargas-Arenas, I Daboin, Y Barrios, J A Pinto, N E Bianco.   

Abstract

Thirty silent lupus nephritis (SLN) patients were compared to 16 individuals bearing overt lupus nephritis (OLN). Results included: years of systemic lupus erythematosus (SLE) diagnosis were significantly earlier (4.6 +/- 2.8 years) in SLN than in OLN (7.18 +/- 3.61) (P < 0.05). Neurological compromise, hypertension, normocitic anemia and lymphopenia were significantly prevalent in OLN than in SLN (P < 0.05). Beside normal urinary sediment and renal function tests, the SLN group showed a moderate increase of both activity (AI) and chronicity (CI) renal pathology index when compared to highly increased AI and CI in OLN (P < 0.05). Seventy percent of SLN patients were ISN/RPS Classes I (6.6%) and II (63.3%) while 81% of OLN cases were Classes III, IV (37.5%) and V. IgG, IgA, IgM, lambda chain, C3 and fibrinogen immune deposits were found in 90% or over in both SLN and OLN individuals while in 60% or over, both groups also showed kappa chain, Clq and C4 deposits. While prevalence of ANA, anti-dsDNA and anti-C1q antibodies were similar in both groups, anti-histone, anti-RNP, CIC and CH50 serum levels were significantly different in OLN versus SLN (P < 0.05). We strongly suggest that indeed SLN is the earliest stage in the natural history of lupus nephritis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17211989     DOI: 10.1177/0961203306070002

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  15 in total

1.  Outcome and predictors of kidney disease progression in Puerto Ricans with systemic lupus erythematosus initially presenting with mild renal involvement.

Authors:  Mariely Nieves-Plaza; Ana P Ortiz; Marilú Colón; María J Molina; Lesliane E Castro-Santana; Vanessa E Rodríguez; Angel M Mayor; Luis M Vilá
Journal:  J Clin Rheumatol       Date:  2011-06       Impact factor: 3.517

2.  Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis.

Authors:  Tamar Rubinstein; Milena Pitashny; Benjamin Levine; Noa Schwartz; Julie Schwartzman; Elena Weinstein; Jose M Pego-Reigosa; Tim Y-T Lu; David Isenberg; Anisur Rahman; Chaim Putterman
Journal:  Rheumatology (Oxford)       Date:  2010-02-09       Impact factor: 7.580

3.  Short- and Long-Term Progression of Kidney Involvement in Systemic Lupus Erythematosus Patients with Low-Grade Proteinuria.

Authors:  Shudan Wang; Allan Spielman; Mindy Ginsberg; Michelle Petri; Brad H Rovin; Jill Buyon; Anna Broder
Journal:  Clin J Am Soc Nephrol       Date:  2022-07-26       Impact factor: 10.614

Review 4.  A Histology-Guided Approach to the Management of Patients with Lupus Nephritis: Are We There Yet?

Authors:  Bogdan Obrișcă; Alexandra Vornicu; Alexandru Procop; Vlad Herlea; George Terinte-Balcan; Mihaela Gherghiceanu; Gener Ismail
Journal:  Biomedicines       Date:  2022-06-15

Review 5.  Use of biomarkers in the management of children with lupus.

Authors:  Elisabeth Binder; Monika Edelbauer
Journal:  Curr Rheumatol Rep       Date:  2013-03       Impact factor: 4.592

6.  Deficiency of activating Fcγ-receptors reduces hepatic clearance and deposition of IC and increases CIC levels in mercury-induced autoimmunity.

Authors:  Klara Martinsson; Thomas Skogh; Seyed Ali Mousavi; Trond Berg; Jan-Ingvar Jönsson; Per Hultman
Journal:  PLoS One       Date:  2010-10-15       Impact factor: 3.240

7.  Urinary monocyte chemotactic protein-1 and transforming growth factor-β in systemic lupus erythematosus.

Authors:  S Torabinejad; R Mardani; Z Habibagahi; J Roozbeh; P Khajedehi; M Pakfetrat; M A Banihashemi; S J Banihashemi
Journal:  Indian J Nephrol       Date:  2012-01

Review 8.  Mesangial cell-specific antibodies are central to the pathogenesis of lupus nephritis.

Authors:  Guillaume Seret; Yannick Le Meur; Yves Renaudineau; Pierre Youinou
Journal:  Clin Dev Immunol       Date:  2011-11-28

Review 9.  Renal involvement in autoimmune connective tissue diseases.

Authors:  Andreas Kronbichler; Gert Mayer
Journal:  BMC Med       Date:  2013-04-04       Impact factor: 8.775

10.  Chapter 12: Lupus nephritis.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.